
Meta-regression coefficients, by drug class
========================================================================
                Outcome               Class  Slope  CI.lb  CI.ub P-value
------------------------------------------------------------------------
1      Cardiovascular Mortality      GLP-1RA 0.783  -3.518 5.083  0.721 
2                MACE                GLP-1RA 0.961  -3.496 5.418  0.673 
3  Hospitalization for Heart Failure GLP-1RA 1.299  -2.514 5.112  0.504 
4       Composite Renal Outcome      GLP-1RA -0.943 -7.44  5.554  0.776 
5         All-cause Mortality        GLP-1RA 0.125  -4.379 4.63   0.957 
6        Myocardial Infarction       GLP-1RA  1.35  -3.309 6.008  0.57  
7               Stroke               GLP-1RA -0.771 -4.678 3.136  0.699 
8      Cardiovascular Mortality      SGLT2i  0.481  -0.048 1.01   0.075 
9                MACE                SGLT2i  1.879  -0.11  3.868  0.064 
10 Hospitalization for Heart Failure SGLT2i   1.44  1.034  1.845    0   
11      Composite Renal Outcome      SGLT2i   0.23  -0.524 0.985  0.55  
12        All-cause Mortality        SGLT2i  0.387  -0.082 0.856  0.106 
13       Myocardial Infarction       SGLT2i  -0.151 -2.779 2.478  0.91  
14              Stroke               SGLT2i  -0.078 -2.905 2.748  0.957 
------------------------------------------------------------------------
Absolute risk difference and baseline cardiovascular risk               
